“…CD8+ and CD4+ T cells from T1D patients target a wide array of epitopes within GAD65 molecule [92,316,[318][319][320][321][322], insulin and proinsulin [91,[323][324][325], IA-2 [316,317,326], IGRP [323,327,328], I-A2b [327,328], islet amyloid polypeptide (IAPP) [327][328][329], and glial fibrillary acidic protein (GFAP) [328] as comprehensively summarized in a review updated to the end of 2006 [330]. More recently, a few more epitopes have been described, as GAD536-545 [316], other IGRP fragments, among which IGRP 211-219 and 222-230 [331], and several novel insulinand proinsulin-derived peptides targeted by CD8+ [323,332,333] and CD4+ T cells [334].…”